These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma]. Huang HQ, Bu Q, Xia ZJ, Lin XB, Wang FH, Li YH, Peng YL, Pan ZH, Wang SS, Lin TY, Jiang WQ, Guan ZZ. Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686 [Abstract] [Full Text] [Related]
6. Does follicularity in large cell lymphoma predict outcome after autologous stem cell transplantation? Krishnan A, Nademanee A, Fung H, Angelopoulou M, Molina A, Gaal K, Dagis A, Palmer J, Alvarnas J, Slovak M, Kogut N, Popplewell L, Rodriguez R, Schriber J, Wang S, Forman SJ. Biol Blood Marrow Transplant; 2006 Jun; 12(6):641-7. PubMed ID: 16737937 [Abstract] [Full Text] [Related]
7. Autologous stem cell transplantation in lymphoma. Schmitz N, Buske C, Gisselbrecht C. Semin Hematol; 2007 Oct; 44(4):234-45. PubMed ID: 17961722 [Abstract] [Full Text] [Related]
8. Progressive disease following autologous transplantation in patients with chemosensitive relapsed or primary refractory Hodgkin's disease or aggressive non-Hodgkin's lymphoma. Kewalramani T, Nimer SD, Zelenetz AD, Malhotra S, Qin J, Yahalom J, Moskowitz CH. Bone Marrow Transplant; 2003 Oct; 32(7):673-9. PubMed ID: 13130314 [Abstract] [Full Text] [Related]
12. Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphoma. Andreadis C, Schuster SJ, Chong EA, Svoboda J, Luger SM, Porter DL, Tsai DE, Nasta SD, Elstrom RL, Goldstein SC, Downs LH, Mangan PA, Cunningham KA, Hummel KA, Gimotty PA, Siegel DL, Glatstein E, Stadtmauer EA. Bone Marrow Transplant; 2005 Dec; 36(11):955-61. PubMed ID: 16205727 [Abstract] [Full Text] [Related]
13. The role of hematopoietic stem cell transplantation in non-Hodgkin lymphoma. Villanueva ML, Vose JM. Clin Adv Hematol Oncol; 2006 Jul; 4(7):521-30. PubMed ID: 17147239 [Abstract] [Full Text] [Related]
17. Autologous stem cell transplantation for clinically aggressive non-Hodgkin's lymphoma: the role of preparative regimens. Salar A, Sierra J, Gandarillas M, Caballero MD, Marín J, Lahuerta JJ, García-Conde J, Arranz R, León A, Zuazu J, García-Laraña J, López-Guillermo A, Sanz MA, Grañena A, García JC, Conde E, GEL/TAMO Spanish Cooperative Group. Bone Marrow Transplant; 2001 Feb; 27(4):405-12. PubMed ID: 11313670 [Abstract] [Full Text] [Related]
18. Autologous stem cell transplantation in first-line treatment of high-risk aggressive non-Hodgkin's lymphoma. Vranovsky A, Ladicka M, Lakota J. Neoplasma; 2008 Feb; 55(2):107-12. PubMed ID: 18652043 [Abstract] [Full Text] [Related]